Brexit must not disrupt drug R&D, say pharma chiefs https://t.co/svvsAYITWF via @FT
— The Propell Group (@ThePropellGroup) July 7, 2017
#healthtech
Brexit must not disrupt drug R&D, say pharma chiefs https://t.co/svvsAYITWF via @FT
— The Propell Group (@ThePropellGroup) July 7, 2017
#healthtech